Form 8-K - Current report:
SEC Accession No. 0001193125-12-360928
Filing Date
2012-08-17
Accepted
2012-08-17 17:18:23
Documents
3
Period of Report
2012-08-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d399852d8k.htm 8-K 13068
2 PRESS RELEASE d399852dex991.htm EX-99.1 6358
3 GRAPHIC g399852g13w95.jpg GRAPHIC 6385
  Complete submission text file 0001193125-12-360928.txt   29791
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 121043297
SIC: 2835 In Vitro & In Vivo Diagnostic Substances